Skip to main content
Novo Nordisk A/S (CPH:NOVO.B)
Denmark flag Denmark · Delayed Price · Currency is DKK
411.10
+2.20 (0.54%)
Apr 24, 2025, 2:45 PM CET

Novo Nordisk Revenue

In the year 2024, Novo Nordisk had annual revenue of 290.40B DKK with 25.03% growth. Novo Nordisk had revenue of 85.68B in the quarter ending December 31, 2024, with 30.09% growth.

Revenue
290.40B
Revenue Growth
+25.03%
P/S Ratio
6.25
Revenue / Employee
3.78M
Employees
77,349
Market Cap
1,815.13B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024290.40B58.14B25.03%
Dec 31, 2023232.26B55.31B31.26%
Dec 31, 2022176.95B36.15B25.68%
Dec 31, 2021140.80B13.85B10.91%
Dec 31, 2020126.95B4.93B4.04%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Coloplast 27.45B
Genmab 21.53B
Demant 22.42B
ALK-Abelló 5.54B
Ambu A/S 5.65B
Zealand Pharma 62.69M
H. Lundbeck 22.00B
GN Store Nord 17.99B
Revenue Rankings

Novo Nordisk News

More News